{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T12:02:40Z","timestamp":1766318560465,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bcmd.2010.10.014","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T04:45:08Z","timestamp":1289969108000},"page":"34-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease"],"prefix":"10.1016","volume":"46","author":[{"given":"J\u00e9r\u00f4me","family":"Stirnemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Boutten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsene","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djazia","family":"Heraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Fantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Mentr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Belmatoug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.10.014_bb0005","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.256.5058.794","article-title":"Gaucher disease: new molecular approaches to diagnosis and treatment","volume":"256","author":"Beutler","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0015","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJM197606242942609","article-title":"Elevation of serum angiotensin-converting enzyme in Gaucher's disease","volume":"294","author":"Lieberman","year":"1976","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Med. Baltim."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0268-960X(88)90009-4","article-title":"Gaucher disease","volume":"2","author":"Beutler","year":"1988","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0030","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/bmj.286.6381.1864","article-title":"Serum ferritin concentration in Gaucher's disease","volume":"286","author":"Morgan","year":"1983","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/bcmd.2002.0511","article-title":"Correlation of bone marrow response with hematological, biochemical, and visceral responses to enzyme replacement therapy of nonneuronopathic (type 1) Gaucher disease in 30 adult patients","volume":"28","author":"Poll","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","article-title":"Hyperferritinemia and iron overload in type 1 Gaucher disease","volume":"85","author":"Stein","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0045","first-page":"227","article-title":"Elevation of serum acid phosphatase in Gaucher's disease","volume":"23","author":"Tuchman","year":"1956","journal-title":"J. Mt. Sinai Hosp."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830190305","article-title":"Tartrate-resistant acid phosphatase staining of monocytes in Gaucher disease","volume":"19","author":"Troy","year":"1985","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","article-title":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease","volume":"35","author":"Deegan","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cccn.2004.02.018","article-title":"Correlation of surrogate markers of Gaucher disease. Implications for long-term follow-up of enzyme replacement therapy","volume":"344","author":"Cabrera-Salazar","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0065","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/cs0560083","article-title":"Binding of human serum ferritin to concanavalin A","volume":"56","author":"Worwood","year":"1979","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/bj1570097","article-title":"The purification and properties of ferritin from human serum","volume":"157","author":"Worwood","year":"1976","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0080","first-page":"890","article-title":"Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease","volume":"21","author":"van Reeth","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V90.2.814","article-title":"Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA","volume":"90","author":"Cazzola","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00262707","article-title":"Biochemical analysis of ferritin subunits in sera from adult Still's disease patients","volume":"15","author":"Higashi","year":"1995","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.59.5.347","article-title":"Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease","volume":"59","author":"Vignes","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0100","first-page":"2315","article-title":"Ferritin subunits in sera and synovial fluids from patients with rheumatoid arthritis","volume":"25","author":"Ota","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/clinchem\/28.4.569","article-title":"Beta-glucosidase assays in the diagnosis of Gaucher's disease","volume":"28","author":"Daniels","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0110","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood-2003-09-3050","article-title":"Regulated secretion of glycosylated human ferritin from hepatocytes","volume":"103","author":"Ghosh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0115","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1016\/S0021-9258(18)98608-4","article-title":"The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity","volume":"266","author":"von Heijne","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3324\/haematol.2008.000125","article-title":"A new missense mutation in the L ferritin-coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload","volume":"94","author":"Kannengiesser","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2010.10.014_bb0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0268-960X(90)90006-E","article-title":"Ferritin","volume":"4","author":"Worwood","year":"1990","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJM197501092920219","article-title":"Letter: iron distribution in adult-type Gaucher's disease","volume":"292","author":"Lorber","year":"1975","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","article-title":"Plasma and metabolic abnormalities in Gaucher's disease","volume":"10","author":"Aerts","year":"1997","journal-title":"Bailli\u00e8res Clin. Haematol."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0140","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0145","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0150","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.23415","article-title":"Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome","volume":"58","author":"Fardet","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0155","first-page":"1027","article-title":"High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation","volume":"30","author":"Lambotte","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcmd.2010.10.014_bb0160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12185-009-0391-5","article-title":"Early diagnostic value of low percentage of glycosylated ferritin in secondary hemophagocytic lymphohistiocytosis","volume":"90","author":"Wang","year":"2009","journal-title":"Int. J. Hematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961000255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961000255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:30Z","timestamp":1761049650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997961000255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S107997961000255X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.014","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}